GlobeNewswire: Integra LifeSciences Holdings Corporation Contains the last 10 of 771 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T14:05:00ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/03/11/2843778/0/en/Integra-LifeSciences-Launches-MicroMatrix-Flex-to-Provide-Convenient-Access-to-Hard-to-Reach-Areas-in-Complex-Cases.html?f=22&fvtc=4&fvtv=682Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases2024-03-11T12:30:00Z<![CDATA[Novel system features flexible tip to deliver flowable version of the Urinary Bladder Matrix (UBM) technology Novel system features flexible tip to deliver flowable version of the Urinary Bladder Matrix (UBM) technology]]>MicroMatrix®Flex is a dual-syringe system enabling the convenient mixing and precise delivery of MicroMatrix® paste. MicroMatrix®Flexhttps://www.globenewswire.com/news-release/2024/02/28/2836726/0/en/Integra-LifeSciences-Announces-Leadership-Transition-Plan.html?f=22&fvtc=4&fvtv=682Integra LifeSciences Announces Leadership Transition Plan2024-02-28T11:00:00Z<![CDATA[Jan De Witte to retire as CEO by the end of 2024Stuart Essig appointed executive chairman of the Board]]>https://www.globenewswire.com/news-release/2024/02/28/2836732/0/en/Integra-LifeSciences-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-2024-Financial-Guidance.html?f=22&fvtc=4&fvtv=682Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance2024-02-28T11:00:00Z<![CDATA[PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2023.]]>https://www.globenewswire.com/news-release/2024/02/07/2825291/0/en/Integra-LifeSciences-to-Host-Fourth-Quarter-and-Full-Year-2023-Financial-Results-Conference-Call-on-February-28-2024.html?f=22&fvtc=4&fvtv=682Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 20242024-02-07T14:15:00Z<![CDATA[PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.]]>https://www.globenewswire.com/news-release/2024/01/05/2804889/0/en/Integra-LifeSciences-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html?f=22&fvtc=4&fvtv=682Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference2024-01-05T21:30:00Z<![CDATA[PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the 42nd Annual J.P. Morgan Healthcare conference on January 10, 2024 at 1:30pm ET.]]>https://www.globenewswire.com/news-release/2023/12/13/2795373/0/en/Integra-LifeSciences-Announces-Definitive-Agreement-to-Acquire-Acclarent.html?f=22&fvtc=4&fvtv=682Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®2023-12-13T11:15:00Z<![CDATA[PRINCETON, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced that it has entered into a definitive agreement to acquire Acclarent, Inc. from Ethicon, Inc., a Johnson & Johnson MedTech company for $275 million in cash at closing, subject to customary purchase price adjustments, and an additional $5 million upon the achievement of certain regulatory milestones. Acclarent is an innovator and market leader in ENT procedures and upon closing, Integra will be one of the leading providers of ENT products and technologies.]]>https://www.globenewswire.com/news-release/2023/12/12/2795019/0/en/Integra-LifeSciences-Appoints-Jeff-Graves-Ph-D-to-Board-of-Directors.html?f=22&fvtc=4&fvtv=682Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors2023-12-12T17:00:00Z<![CDATA[PRINCETON, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Jeff Graves, Ph.D., president and chief executive officer of 3D Systems Corporation, was appointed to the company’s board of directors, effective immediately. With the appointment of Dr. Graves, Integra has added four new directors since 2021.]]>Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of DirectorsJeff Graveshttps://www.globenewswire.com/news-release/2023/10/25/2766297/0/en/Integra-LifeSciences-Reports-Third-Quarter-2023-Financial-Results.html?f=22&fvtc=4&fvtv=682Integra LifeSciences Reports Third Quarter 2023 Financial Results2023-10-25T10:00:00Z<![CDATA[PRINCETON, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2023.]]>https://www.globenewswire.com/news-release/2023/10/04/2754498/0/en/Integra-LifeSciences-to-Host-Third-Quarter-2023-Financial-Results-Conference-Call-on-October-25-2023.html?f=22&fvtc=4&fvtv=682Integra LifeSciences to Host Third Quarter 2023 Financial Results Conference Call on October 25, 20232023-10-04T12:00:00Z<![CDATA[PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2023 financial results on Wednesday, October 25, 2023, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.]]>https://www.globenewswire.com/news-release/2023/09/01/2736366/0/en/Integra-LifeSciences-to-Present-at-the-2023-Wells-Fargo-Healthcare-Conference.html?f=22&fvtc=4&fvtv=682Integra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference2023-09-01T21:04:03Z<![CDATA[PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2023 Wells Fargo Healthcare Conference on September 6, 2023 at 1:30 p.m. EST.]]>